XML 102 R86.htm IDEA: XBRL DOCUMENT v3.6.0.2
Condensed Consolidating Guarantor Financial Statements Details SCF (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flow from operating activities:      
Net Cash Provided by (Used in) Operating Activities $ 96,854 $ 92,749 $ 97,679
Cash flow from investing activities:      
Loan receivables, net of cash repayments (16,072) (3,716) (2,470)
Purchases of property and equipment (33,863) (21,073) (23,954)
Portion of aggregate merger consideration paid in cash, net of cash acquired (29,866) (46,887) (58,942)
Portion of aggregate merger consideration paid in cash, net of cash acquired (8,250) 0 0
Proceeds from sale of common stock of Enova 62,084 0 0
Net cash flow used in investing activities (25,967) (71,676) (85,366)
Cash flow from financing activities:      
Borrowings from revolving credit facilities 400,000 120,000 50,000
Repayments of revolving credit facilities (198,000) (84,400) (209,600)
Repayments of debt assumed with merger and other acquisitions (238,532) 0 0
Issuance of senior unsecured notes 0 0 200,000
Debt issuance costs paid (2,373) (407) (6,610)
Purchases of treasury stock 0 (39,974) (43,947)
Proceeds from exercise of share-based compensation awards 0 9,895 5,270
Income tax benefit from exercise of stock options 0 5,126 4,141
Payment of minimum withholding taxes on net share settlement of stock options exercised 0 (1,113) 0
Intercompany dividends paid 19,808    
Net cash flow provided by (used in) financing activities (58,713) 9,127 (9,098)
Effect of exchange rates on cash (9,173) (11,238) (5,866)
Change in cash and cash equivalents 3,001 18,962 (2,651)
Cash and cash equivalents at beginning of the year 86,954 67,992 70,643
Cash and cash equivalents at end of the year 89,955 86,954 67,992
Consolidating Eliminations      
Cash flow from operating activities:      
Net Cash Provided by (Used in) Operating Activities (187,720) (66,392) (70,866)
Cash flow from investing activities:      
Loan receivables, net of cash repayments 0 0 0
Purchases of property and equipment 0 0 0
Portion of aggregate merger consideration paid in cash, net of cash acquired 0    
Portion of aggregate merger consideration paid in cash, net of cash acquired 0 0 0
Proceeds from sale of common stock of Enova 0    
Investing activity with subsidiaries 329,422 43,890 49,570
Net cash flow used in investing activities 329,422 43,890 49,570
Cash flow from financing activities:      
Borrowings from revolving credit facilities 0 0 0
Repayments of revolving credit facilities 0 0 0
Repayments of debt assumed with merger and other acquisitions 0   0
Issuance of senior unsecured notes     0
Debt issuance costs paid 0 0 0
Purchases of treasury stock   0 0
Proceeds from exercise of share-based compensation awards   0 0
Common stock dividends paid 0    
Income tax benefit from exercise of stock options   0 0
Payment of minimum withholding taxes on net share settlement of stock options exercised   0  
Proceeds from intercompany financing related activity (329,422) (43,890) (49,570)
Intercompany dividends paid 187,720 66,392 70,866
Net cash flow provided by (used in) financing activities (141,702) 22,502 21,296
Effect of exchange rates on cash 0 0 0
Change in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of the year 0 0 0
Cash and cash equivalents at end of the year 0 0 0
Parent Company      
Cash flow from operating activities:      
Net Cash Provided by (Used in) Operating Activities 153,924 32,753 42,632
Cash flow from investing activities:      
Loan receivables, net of cash repayments 0 0 0
Purchases of property and equipment (1,118) (329) (839)
Portion of aggregate merger consideration paid in cash, net of cash acquired 0    
Portion of aggregate merger consideration paid in cash, net of cash acquired 0 0 0
Proceeds from sale of common stock of Enova 0    
Investing activity with subsidiaries (329,422) (43,890) (49,570)
Net cash flow used in investing activities (330,540) (44,219) (50,409)
Cash flow from financing activities:      
Borrowings from revolving credit facilities 400,000 120,000 50,000
Repayments of revolving credit facilities (198,000) (84,400) (209,600)
Repayments of debt assumed with merger and other acquisitions 0   (8,352)
Issuance of senior unsecured notes     200,000
Debt issuance costs paid (2,373) (407) (6,610)
Purchases of treasury stock   (39,974) (43,947)
Proceeds from exercise of share-based compensation awards   9,895 5,270
Common stock dividends paid (19,808)    
Income tax benefit from exercise of stock options   5,126 4,141
Payment of minimum withholding taxes on net share settlement of stock options exercised   (1,113)  
Proceeds from intercompany financing related activity 0 0 0
Intercompany dividends paid 0 0 0
Net cash flow provided by (used in) financing activities 179,819 9,127 (9,098)
Effect of exchange rates on cash 0 0 0
Change in cash and cash equivalents 3,203 (2,339) (16,875)
Cash and cash equivalents at beginning of the year 5,460 7,799 24,674
Cash and cash equivalents at end of the year 8,663 5,460 7,799
Guarantor Subsidiaries      
Cash flow from operating activities:      
Net Cash Provided by (Used in) Operating Activities 82,030 59,675 62,403
Cash flow from investing activities:      
Loan receivables, net of cash repayments 1,909 1,803 2,785
Purchases of property and equipment (20,718) (6,919) (8,097)
Portion of aggregate merger consideration paid in cash, net of cash acquired (8,250)    
Portion of aggregate merger consideration paid in cash, net of cash acquired (2,433) (29,617) (16,417)
Proceeds from sale of common stock of Enova 62,084    
Investing activity with subsidiaries 0 0 0
Net cash flow used in investing activities 32,592 (34,733) (21,729)
Cash flow from financing activities:      
Borrowings from revolving credit facilities 0 0 0
Repayments of revolving credit facilities 0 0 0
Repayments of debt assumed with merger and other acquisitions (232,000)   0
Issuance of senior unsecured notes     0
Debt issuance costs paid 0 0 0
Purchases of treasury stock   0 0
Proceeds from exercise of share-based compensation awards   0 0
Common stock dividends paid 0    
Income tax benefit from exercise of stock options   0 0
Payment of minimum withholding taxes on net share settlement of stock options exercised   0  
Proceeds from intercompany financing related activity 329,138 36,536 24,514
Intercompany dividends paid (180,671) (60,859) (66,623)
Net cash flow provided by (used in) financing activities (83,533) (24,323) (42,109)
Effect of exchange rates on cash 0 0 0
Change in cash and cash equivalents 31,089 619 (1,435)
Cash and cash equivalents at beginning of the year 3,765 3,146 4,581
Cash and cash equivalents at end of the year 34,854 3,765 3,146
Non-Guarantor Subsidiaries      
Cash flow from operating activities:      
Net Cash Provided by (Used in) Operating Activities 48,620 66,713 63,510
Cash flow from investing activities:      
Loan receivables, net of cash repayments (17,981) (5,519) (5,255)
Purchases of property and equipment (12,027) (13,825) (15,018)
Portion of aggregate merger consideration paid in cash, net of cash acquired 0    
Portion of aggregate merger consideration paid in cash, net of cash acquired (27,433) (17,270) (42,525)
Proceeds from sale of common stock of Enova 0    
Investing activity with subsidiaries 0 0 0
Net cash flow used in investing activities (57,441) (36,614) (62,798)
Cash flow from financing activities:      
Borrowings from revolving credit facilities 0 0 0
Repayments of revolving credit facilities 0 0 0
Repayments of debt assumed with merger and other acquisitions (6,532)   0
Issuance of senior unsecured notes     0
Debt issuance costs paid 0 0 0
Purchases of treasury stock   0 0
Proceeds from exercise of share-based compensation awards   0 0
Common stock dividends paid 0    
Income tax benefit from exercise of stock options   0 0
Payment of minimum withholding taxes on net share settlement of stock options exercised   0  
Proceeds from intercompany financing related activity 284 7,354 25,056
Intercompany dividends paid (7,049) (5,533) (4,243)
Net cash flow provided by (used in) financing activities (13,297) 1,821 20,813
Effect of exchange rates on cash (9,173) (11,238) (5,866)
Change in cash and cash equivalents (31,291) 20,682 15,659
Cash and cash equivalents at beginning of the year 77,729 57,047 41,388
Cash and cash equivalents at end of the year 46,438 77,729 57,047
Consolidated      
Cash flow from operating activities:      
Net Cash Provided by (Used in) Operating Activities 96,854 92,749 97,679
Cash flow from investing activities:      
Loan receivables, net of cash repayments (16,072) (3,716) (2,470)
Purchases of property and equipment (33,863) (21,073) (23,954)
Portion of aggregate merger consideration paid in cash, net of cash acquired (8,250)    
Portion of aggregate merger consideration paid in cash, net of cash acquired (29,866) (46,887) (58,942)
Proceeds from sale of common stock of Enova 62,084    
Investing activity with subsidiaries 0 0 0
Net cash flow used in investing activities (25,967) (71,676) (85,366)
Cash flow from financing activities:      
Borrowings from revolving credit facilities 400,000 120,000 50,000
Repayments of revolving credit facilities (198,000) (84,400) (209,600)
Repayments of debt assumed with merger and other acquisitions (238,532)   (8,352)
Issuance of senior unsecured notes     200,000
Debt issuance costs paid (2,373) (407) (6,610)
Purchases of treasury stock   (39,974) (43,947)
Proceeds from exercise of share-based compensation awards   9,895 5,270
Common stock dividends paid (19,808)    
Income tax benefit from exercise of stock options   5,126 4,141
Payment of minimum withholding taxes on net share settlement of stock options exercised   (1,113)  
Proceeds from intercompany financing related activity 0 0 0
Intercompany dividends paid 0 0 0
Net cash flow provided by (used in) financing activities (58,713) 9,127 (9,098)
Effect of exchange rates on cash (9,173) (11,238) (5,866)
Change in cash and cash equivalents 3,001 18,962 (2,651)
Cash and cash equivalents at beginning of the year 86,954 67,992 70,643
Cash and cash equivalents at end of the year $ 89,955 $ 86,954 $ 67,992